Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients

Detalles Bibliográficos
Autores principales: Hifumi, Toru, Isokawa, Shutaro, Otani, Norio, Ishimatsu, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422471/
https://www.ncbi.nlm.nih.gov/pubmed/32787901
http://dx.doi.org/10.1186/s13054-020-03227-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422471/
https://www.ncbi.nlm.nih.gov/pubmed/32787901
http://dx.doi.org/10.1186/s13054-020-03227-4

Ejemplares similares